Catalyst Wire Dossier Catalyst Wire Dossier

Ad26.RSV.preF

Ad26.RSV.preF · Janssen Vaccines & Prevention B.V.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Ad26.RSV.preF, covering 2019-02-19 to 2024-02-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older [Phase 3]

See pricing